43 results about "Cerebral Concussions" patented technology

Systems and methods provided utilize gaze-tracking to measure quantitatively and accurately the ability of an athlete or other subject suspected of a concussion to maintain gaze within a figure-eight pattern during a given period of time. The fixation icon is presented at increasing velocities, with multiple staged velocities constituting the preferred embodiment. Utilizing a figure-eight pattern is preferred. Total tracking error time is tabulated during each velocity stage of the test protocol, and total tracking error time occurring during a given velocity stage is compared to a subject's baseline, e.g., a pre-season Individual Bioperformance Level (IBL) for that velocity stage. Systems and methods disclosed may be used to help prevent debilitating neurological damage in our athlete population, as well as having important military applications related to PTSD, and to other mission-critical performance endeavors.

In an infrared camera configuration, a modular goggle assembly can diagnose patients having vestibular dysfunction, concussion, or other maladies observable with an examination of the eyes. In a virtual reality display configuration, the assembly can be used to provide treatment to patients once the cause of the illness or malady is determined. The assembly is lightproof, mobile, and easily configurable.

Methods and systems for assessing a health state of a person via eye movement-driven biometric systems are provided. Examples of the health states that it would be possible to detect with such a system are but not limited to brain injuries (e.g., concussions), dementia, Parkinson's disease, post-traumatic stress syndrome, schizophrenia, fatigue, cybersickness, autism, Bipolar Disorder and other health conditions that manifest themselves in abnormal behavior of the human visual system. Described methods and systems can also detect influence of alcohol and / or drugs. The system extracts biometric template of a person by deriving features from the captured eye movement signal. The system may compare the difference between previous healthy state of a tested person and newly captured template or an averaged biometric template created from the records of multiple healthy people state of multiple people and a newly captured template from a person who needs to be tested. Based on the difference between the templates, a decision of a health state of a person is made. Described methods and systems may work on any device that has eye tracking capabilities including but not limited to desktop mounted eye tracking systems, head mounted eye tracking systems such as Virtual Reality and Augmented Reality or stand-alone mounted eye tracking systems.

A cushion, using magnetic friction as base protection is specifically tested and designed for use in helmets to minimize the risk of concussions. The cushion can be used in a two layer helmet where the magnets are used to repel the impact normally taken straight to the head. The magnets can be placed in between the layers to not only take the impact, but also give that force back towards the source, creating a cushion like no other helmet. With this two-layer system, one can measure that the first layer of magnets takes the hit and uses the second layer to push back off of. This movement that the helmet takes significantly improves protection of the brain as compared to conventional helmets.

Methods and materials are disclosed for evaluating head brain injuries that do not involve blood loss or skull fractures, such as possible concussions. These methods and materials involve bioreagents (such as monoclonal antibodies, single-stranded DNA or RNA, etc.) affixed to computer-readable devices handled by electronic readers that can interact with portable computers (such as laptops, pads or tablets, smart phones, etc.). The bioreagents will detect the presence and concentration of at least two metabolites that are released by mitochondria in response to cellular damage. Additional bioreagents may be included, for detecting and quantifying other damage-associated molecular patterns (DAMP's). When used along with cognitive, reasoning, and / or response tests, this type of analysis can help non-physicians assess the severity of, and proper responses to, head traumas that otherwise are difficult or impossible to reliably evaluate.

The present invention discloses a neck strengthening apparatus adaptable to provide physical conditioning and therapeutic benefits. The neck strengthening apparatus comprises a headgear that employing a weight member to provide a predetermined mechanical load to user's neck and spine. The headgear with weight member could be used to exercise the neck as well as to reduce the incidents and severity of concussions and other injuries. Various fastener members are used to detachably fasten the weight member to the anterior or forehead area of the headgear. The weight member could be fastened at a temporo-mandibular joint (TMJ) of the headgear. The neck strengthening apparatus can effectively strengthening and conditioning the user's neck muscles. The apparatus is configured to target on the neck muscles effectively during exercises and in practice sessions.

Embodiments relate to a system for generating simulated eye movements and eye responses related to concussion symptoms for training medical practitioners. The system includes a computer device with a display that displays the pair of simulated eyes. Scenarios are generated and executed, in which simulated eye movements and responses to external stimuli are representative of typical symptoms associated with having a concussion. A user (e.g., medical trainee or medical trainer) provides external inputs e.g., voice commands, stylus movements, etc.) and assess eye movements provided by the scenarios and eye responses to the external inputs.

Compositions and methods for mitigating a pathology following brain trauma or at least a portion of a cascade of a pathology associated therewith, including compositions and methods for treating concussion or preventing the onset of anecrotic cell death in neurons. Exemplary compositions for treating concussion include an active compound comprising one or more of: phenserine, a phenserine metabolite, a phenserine prodrug, or combinations thereof; and one or more pharmaceutically acceptable excipients. The one or more excipients can be combined with the active compound to form an extended, controlled-release medicament that delivers a therapeutic concentration of the active compound over a period of time. Exemplary methods include administering a therapeutic dose of the active compound and, optionally, a therapeutically acceptable dose of a second active compound, and, optionally, maintaining the therapeutic doses of the active and optional second active compounds at therapeutically effective concentrations over a period of time.